Alec B. Wilkens

2.0k citations
4 papers · 1.5k indexed · 2 hit papers · h-index 3
Topics
CRISPR and Genetic Engineering (2 papers)CAR-T cell therapy research (2 papers)RNA Interference and Gene Delivery (1 paper)
Partner nations
United States

In The Last Decade

Alec B. Wilkens

4 papers receiving 1.4k citations

Hit Papers

Chemically modified guide RNAs enhance CRISPR-Cas genome ...201520262018202220152016250500750

Peers

Alec B. Wilkens
Comparison fields: 5 of 66
  • Molecular Biology 1.3k
  • Genetics 446
  • Oncology 218
  • Business and International Management 146
  • Genetics 142
Replace Sruthi Mantri with:
Sruthi Mantri United States
Mara Pavel-Dinu United States
M. Kyle Cromer United States
Carsten T. Charlesworth United States
Carmencita E. Nicolas United States
Timothy Davis United States
Fabrizia Urbinati United States
Jiazhi Hu China
Beeke Wienert Australia
Seok‐Jin Heo United States
Alec B. Wilkens relative to Sruthi Mantri United States Sruthi Mantri's profile →
Citations per field
00.5×10×20×34.5×
Sruthi Mantri · 1×
Citations per year

Countries citing papers authored by Alec B. Wilkens

Since Specialization
Citations

This map shows the geographic impact of Alec B. Wilkens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alec B. Wilkens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alec B. Wilkens more than expected).

Fields of papers citing papers by Alec B. Wilkens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alec B. Wilkens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alec B. Wilkens. The network helps show where Alec B. Wilkens may publish in the future.

Co-authorship network of co-authors of Alec B. Wilkens

This figure shows the co-authorship network connecting the top 25 collaborators of Alec B. Wilkens. A scholar is included among the top collaborators of Alec B. Wilkens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alec B. Wilkens. Alec B. Wilkens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

About Alec B. Wilkens

Alec B. Wilkens is a scholar working on Immunology, Genetics and Oncology, having authored 4 papers that have together received 1.5k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Business and International Management (146 citations), Aging (63 citations) and Molecular Biology (1.3k citations). Alec B. Wilkens has collaborated with scholars based in United States. Frequent co-authors include Rasmus O. Bak, Ayal Hendel, Matthew H. Porteus, Israel Steinfeld, Subhadeep Roy, Daniel E. Ryan, Andrew Kennedy, Rosa Bacchetta, Laurakay Bruhn and Douglas J. Dellinger. Their work appears in journals such as Nature, Blood and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026